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Evidence suggests that a repertoire of Vibrio cholerae genes are differentially expressed in vivo, and regulation of
virulence factors in vivo may follow a different pathway. Our work was aimed at characterization of in
vivo-grown bacteria and identification of genes that are differentially expressed following infection by RNA
arbitrarily primed (RAP)-PCR fingerprinting. The ligated rabbit ileal loop model was used. The motility of in
vivo-grown bacteria increased by 350% over that of in vitro-grown bacteria. Also, the in vivo-grown cells were
more resistant to killing by human serum. By using the RAP-PCR strategy, five differentially expressed
transcripts were identified. Two in vitro-induced transcripts encoded polypeptides for the leucine tRNA
synthatase and the 50S ribosomal protein, and the three in vivo-induced transcripts encoded the SucA and
MurE proteins and a polypeptide of unknown function. MurE is a protein involved in the peptidoglycan
biosynthetic pathway. The lytic profiles of in vivo- and in vitro-grown cells suspended in distilled water were
compared; the former was found to be slightly less sensitive to lysis. Ultrathin sections of both cells observed
under the transmission electron microscope revealed that in contrast to the usual wavy discontinuous mem-
brane structure of the in vitro-grown cells, in vivo-grown cells had a more rigid, clearly visible double-layered
structure. The V. cholerae murE gene was cloned and sequenced. The sequence contained an open reading frame
of 1,488 nucleotides with its own ribosome-binding site. A plasmid containing the murE gene of V. cholerae was
transformed into V. cholerae 569B, and a transformed strain, 569BME, containing the plasmid was obtained.
Ultrathin sections of 569BME viewed under a transmission electron microscope revealed a slightly more rigid
cell wall than that of wild-type 569B. When V. cholerae 569B and 569BME cells were injected separately into
ligated rabbit ileal loops, the transformed cells had a preference for growth in the ileal loops versus laboratory
conditions.
Cholera is still a major public health problem in developing
countries as well as in some developed countries. The causative
organism, Vibrio cholerae, is a gram-negative curved rod, and
the life-threatening watery diarrhea is largely due to the action
of the secreted cholera toxin on the epithelium of the small
intestine (8). Several lines of evidence suggest that a number of
V. cholerae genes are differentially expressed in vivo following
infection. The major virulence genes of V. cholerae O1 biotype
Classical under the coordinate regulation of the transcriptional
activator ToxR are maximally expressed in vitro. In contrast, in
the intestinal lumen, conditions repress the expression of
ToxR-controlled virulence factors (16, 17). Thus, to induce the
ToxR-controlled virulence genes in vivo, V. cholerae may rec-
ognize other unknown external signals in the host environment
(20). V. cholerae cells are extremely sensitive to a wide variety
of chemicals, particularly hydrophobic compounds and neutral
and anionic detergents, and are much more permeable than
Escherichia coli cells (21). This is primarily due to the presence
of exposed phospholipids in the outer leaflet of the outer
membrane and relatively less negative charge on the polysac-
charide moiety of lipopolysaccharide (21). The murein net-
work of V. cholerae is weak, and the cells lyse rapidly in hypo-
tonic medium as well as in the presence of chelating agents
such as Tris and EDTA (13). Unlike other gram-negative or-
ganisms which are resistant to penicillin, V. cholerae cells are
equally sensitive to penicillin and ampicillin and are much
more sensitive to most of the beta-lactam antibiotics than E.
coli (25).
Recently, using a method based on tnpR operon fusions
encoding a site-specific DNA recombinase, 13 transcriptional
units of V. cholerae were identified that were induced during
infection in an infant-mouse model of cholera. Five of these
were predicted to encode polypeptides with diverse functions
in metabolism, biosynthesis, and motility. One encoded a se-
creted lipase, two seemed to be antisense to genes involved in
motility, and five were predicted to encode polypeptides of
unknown function (3). Using signature-tagged mutagenesis
(STM) to conduct a screen for random insertion mutations
that affect colonization in the suckling mouse model for chol-
era, five mutants with transposon insertions in toxin coregu-
lated pilus (TCP) biogenesis genes were isolated. Insertions in
lipopolysaccharide, biotin, and purine biosynthetic genes were
also found to cause colonization defects. Similar results were
observed for mutations in homologs of pta and ptfA, two genes
involved in phosphate transfer. The screen also identified sev-
eral novel genes, disruption of which also caused colonization
defects in the mouse model (5). Although two different tech-
niques were used, none of the in vivo-induced genes was iden-
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tified twice. Also, it is well known that the genes in the tcp
operon are responsible for colonization. Only one such gene
was isolated, suggesting that only one third of all the genes
responsible could be identified by the STM method. Moreover,
with methods involving transposon mutagenesis, only genes
that are induced in vivo are identified, but the genes that are
repressed may hold some major information regarding the
mechanism of pathogenesis of the organism.
The RNA arbitrarily primed PCR (RAP-PCR) method am-
plifies subsets of an mRNA population and separates the re-
sulting cDNAs by denaturing polyacrylamide gel electrophore-
sis (PAGE). These two steps resulted in a collection of DNA
molecules that were flanked at their 39 and 59 ends by the exact
sequence (and complement) of the arbitrary primer. These in
turn formed templates for high-stringency PCR amplification.
Although the intensities of different bands within the same
fingerprint vary, the intensity of a band between fingerprints
appears to be proportional to the concentration of its corre-
sponding template or mRNA (28). A complete pattern of all
mRNAs expressed in a particular cell is possible with a rea-
sonable number of primer pairs (27). This technique was used
to examine differential gene expression in Salmonella enterica
serovar Typhimurium in response to peroxide treatment (29).
Two identical stress-inducible genes were found in different
parts of the genome. Several differential-display reverse tran-
scriptase-PCR fragments from Legionella pneumophila in-
duced after a 4-h incubation of macrophage-like cells were
identified (9).
In this study, we attempted a characterization of in vivo-
grown bacteria and identification of genes that are differen-
tially expressed following infection by RAP-PCR fingerprint-
ing. We identified a set of genes that are differentially
expressed in vivo, one of which is involved in the peptidoglycan
biosynthetic pathway. We cloned this gene and investigated the
potential role of the gene product in the survival of V. cholerae
in vivo.
MATERIALS AND METHODS
Bacterial strains and plasmids. All bacterial strains and plasmids used in this
study are listed in Table 1. The V. cholerae and E. coli strains were maintained
at 270°C in Luria-Bertani (LB) medium containing 20% (vol/vol) glycerol. E.
coli cells were grown in LB medium or M9 medium, and V. cholerae cells were
grown in NB or LB medium. Ampicillin was used at 100 mg/ml for E. coli and 50
mg/ml for V. cholerae where appropriate. Plasmids were incorporated into V.
cholerae cells by transformation by the method of Panda et al. (18). All cloning
experiments were done in pBluescriptKS1. The plasmids were maintained and
amplified in E. coli strains DH5a and XL1 Blue.
DNA preparation and manipulation. Genomic DNA from V. cholerae 569B
was prepared from proteinase K-digested and cetyltrimethylammonium bro-
mide-precipitated cell lysates by standard procedures (2). Plasmid DNA was
prepared by the alkaline lysis method (14). Restriction enzymes and DNA-
modifying enzymes were purchased from New England BioLabs Inc. (Beverly,
Mass.) and used according to the manufacturer’s recommendations. For South-
ern blotting, restriction enzyme-digested chromosomal or plasmid DNA was
electrophoresed on 1% agarose gels and blotted on nylon membranes (Nytran;
Schleicher & Schuell), using 103 SSC (13 SSC is 0.015 M NaCl plus 0.015 M
sodium citrate) (14). The blots were hybridized with DNA fragments labeled
with [32P]dCTP (Amersham International, Amersham, U.K.) prepared by using
a random-primed labeling kit (New England Biolabs). Subgenomic libraries of V.
cholerae DNA were constructed in plasmid pBluescript. Genomic DNA was
digested with appropriate restriction enzymes, and the fragments within the size
FIG. 1. Swarming behavior of V. cholerae cells grown in vitro (L) and in vivo
(R) on motility agar plates.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype or phenotype Source or reference
Vibrio cholerae
569B Prototroph, highly toxinogenic, biotype Classical, serotype Inaba 17a
569BME 569B containing pAMT150 This study
Escherichia coli
K-12 Wild type Laboratory collection
XL1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F9 proAB lacIqZD15 Tn10
(Tetr)]
Stratagene
DH5a F2 f80d/lacZD M15DlacZYA argF)U169 recA1 endA1 hsdR17 (rk
2 mk
2) supE44
thi-1 gyrA relA1
Bethesda Research Laboratories
CSR603 thr-1 ara-14 leuB6D (gpt-proA)62 lacY1 tsx-33 suppE44 phr-1 galK2 l2 rac recA1
gyrA98 rpsL31 kdgK51 xyl-5 mtl-1 uvrA6
Aziz Shankar
Plasmids
pBluescript KS 2.96 kb, Ampr Stratagene
pRAP1 pBluescript carrying 145-bp V. cholerae murE cDNA fragment This study
pRAP2 pBluescript carrying 331-bp V. cholerae leucyl-tRNA synthase cDNA fragment This study
pRAP3 pBluescript carrying 145-bp V. cholerae cDNA fragment This study
pRAP4 pBluescript carrying 248-bp V. cholerae 50S ribosomal protein cDNA fragment This study
pRAP5 pBluescript carrying 175-bp V. cholerae sucA gene cDNA fragment This study
pAMT200 pBluescript carrying 2-kb KpnI-SacI fragment of V. cholerae genomic DNA This study
pAMT150 pBluescript carrying 1.5-kb PCR fragment of V. cholerae genomic DNA This study
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range of interest were excised from agarose gels, purified, ligated with linearized
and dephosphorylated plasmid pBluescript, and transformed into E. coli accord-
ing to standard recombinant DNA techniques (14).
Ligated rabbit ileal loop model. In vivo growth of V. cholerae strains was
carried out in the rabbit ileal loop model essentially as described by De and
Chatterjee (6). Briefly, rabbits fasted for 48 h were anesthetized, and the small
intestine was tied into consecutive 6-cm and 2-cm segments proximally to the
mesoappendix. An inoculum of 0.5 ml of V. cholerae strains containing about 5 3
106 CFU was introduced into each 6-cm segment, while one loop was inoculated
with saline as a negative control. The intestine was returned to the peritoneal
cavity, and the incision was closed. After 16 to 18 h, the animals were sacrificed,
and the small intestine was removed. Fluid accumulated in each loop was sep-
arately collected and measured. The V. cholerae count in the fluid was measured
by plating on thiosulfate-citrate-bile salt-sucrose (TCBS) agar plates. Although
no fluid accumulated in the loops inoculated with saline, these loops were also
washed and scraped, and bacterial cells in the washings were counted to deter-
mine whether the intestine contained any inhabitant. At least two loops in the
same animal were inoculated with each bacterial strain, and each strain was
tested in at least five individual animals.
Isolation of in vivo-grown bacteria. V. cholerae strains was grown in rabbit ileal
loops. After 16 to 18 h, the animals were sacrificed and the small intestine was
removed. Fluid accumulated in each loop was collected separately. The fluid was
then spun at 1,000 rpm for 5 min to remove the debris. The supernatant was then
centrifuged at 5,000 rpm for 10 min to pellet the bacteria.
Swarm plate assay. V. cholerae cells were stabbed into semisolid agar plates
containing LB (pH 7.2) solidified with 0.3% Bactoagar (Difco). The plates were
incubated at 37°C for 16 to 18 h, and swarm diameters were measured.
Serum assays. Blood was collected from five healthy individuals who gave
informed consent and was then allowed to clot. Serum was collected, pooled, and
stored at 270°C in aliquots. With normal human serum and serum heat treated
by incubation at 56°C for 30 min to inactivate complement components, serum
assays were performed by a previously described procedure with slight modifi-
cation (26). Two different assays were carried out. In one, the concentration of
serum was kept at 35% and 2 3 109 bacterial cells from an exponential-phase or
overnight culture or rabbit intestine were added. The reaction mixture was
incubated at 37°C for 3 h. Counts of viable cells were done by taking samples at
0, 1, 2, and 3 h. Percentages for each time point were obtained from surviving
viable-cell count versus the initial viable-cell count. For each culture condition,
assays were performed at least four different times in 35% serum and 35%
heat-inactivated serum. In the other assay, 5 3 109 bacterial cells isolated and
diluted from an exponential-phase or overnight culture or rabbit intestine were
incubated for 2 h at 37°C with serum and inactivated serum at concentrations of
20, 40, 60, and 80%. Dilutions of samples were plated onto NA plates and
incubated overnight at 37°C, and counts were determined. Percentages for each
serum concentration were obtained from surviving viable-cell count versus the
initial viable-cell count. For each culture condition, assays were performed at
least two different times.
RNA isolation and analysis. For isolation of RNA, cells were grown to the late
logarithmic phase in LB (pH 7.2) or overnight in the rabbit intestine. Total RNA
was extracted and purified by using guanidium isothiocyanate as described else-
where (2). RNA samples (15 to 25 mg/well) were electrophoresed in duplicate in
1% agarose–2.1 M formaldehyde–morpholinepropanesulfonic acid gels, and one
part was stained with ethidium bromide and visualized with UV light to confirm
equal loading of all samples. The other part of the gel was blotted onto nylon
membranes by using 203 SSC and hybridized with labeled probes as described
elsewhere (2).
DNA sequencing. Nucleotide sequence was determined with double-stranded
plasmid DNA as the template either by the dideoxy chain termination method
(24) or by cycle sequencing with the Applied Biosystem Prism dye system (Per-
kin-Elmer). For manual sequencing, [a-35S]dATP and the Sequenase 2.0 DNA
sequencing kit (US Biochemical Corp.) were used according to the manufactur-
er’s instructions.
RAP-PCR fingerprinting of RNA. RAP was performed essentially as described
by Welsh et al. (28). RNA was first treated with RNase-free DNase I (Life
Technologies). The reaction was stopped by adding 0.5 M EDTA, and the RNA
was extracted with phenol-chloroform (1:1), ethanol precipitated, washed, and
dried. To 10 ml of sample containing 200 ng of this DNase-treated RNA dis-
solved in water, arbitrarily chosen primer was added to a final concentration of
1 mM, and the mixture was incubated at 68°C for 10 min and then chilled on ice.
cDNA synthesis buffer (10 ml) containing 5 U of Superscript II RNase H2
reverse transcriptase (Life Technologies), 100 mM Tris-HCl (pH 8.3), 100 mM
KCl, 8 mM MgCl2, 20 mM dithiothreitol, and 2 mM deoxynucleoside triphos-
FIG. 2. Serum assays of behavior of V. cholerae cells grown in vitro (L) and in vivo (R) in 35% serum (S) or 35% heat-inactivated serum (IS) with an inoculum of
2 3 109 cells. Samples were taken in duplicate at the start and each hour for 3 h. Results are shown as percent viability.
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phates was added. First-strand cDNA synthesis was carried out at 37°C for 1 h.
After cDNA synthesis, 10 ml of buffer containing 2 mM Tris-HCl (pH 8.3), 5 mM
KCl, 4 mM MgCl2, 1 mM same arbitrarily chosen primer, 100 mCi of
[a-32P]dCTP (3,000 Ci/mmol), and 0.5 U of Taq polymerase was added to the
20-ml cDNA sample. The thermal cycling parameters were as follows: one low-
stringency cycle; 94°C (5 min), 40°C (5 min), 72°C (5 min); then 30 high-
stringency cycles at 94°C (1 min), 60°C (1 min), and 72°C (2 min). A 10-ml
amount of 80% formamide with bromophenol blue and xylene cyanol dyes was
added to 5 ml of each PCR sample. The samples were heated to 75°C for 15 min
and loaded on a standard 5% polyacrylamide–50% urea sequencing gel prepared
in 13 Tris-borate-EDTA and electrophoresed at 300 V until the xylene cyanol
dye reached the bottom of the gel. The gel was dried under vacuum onto 3MM
paper (Whatman). The RAP fingerprint was visualized by autoradiography using
Kodak X-Omat AR film. The primers used in this study were RSP, AACAGC
TATGACCATG; MSP, GTAAAACGACGGCCAGT; BGA1, GTCATCCGTC
GATTGCCGGA; BGC2, GACCATTGCATAACGCTGAC; BGT3, CCTTAG
TGCGTATTATGT; ARB1, CCATGCGCATGCATGAGA; ARB2, AGAGAG
AAACCCACCAGA; and ARB3, CCGCACGCGCACGCAAGG.
Lysis of whole cells. Cells from an exponential-phase or overnight culture or
rabbit intestine were harvested by centrifugation (6,000 3 g, 10 min) and sus-
pended in distilled water. The extent of lysis was estimated by monitoring the
decrease in A585 with respect to the initial value at time zero.
Assay of stability of pAMT150 in 569BME. V. cholerae 569BME was grown
overnight in the laboratory and in rabbit ileal loops. The bacteria were harvested,
diluted, and plated onto NA and NA plates with ampicillin. Counts of viable cells
were made from these plates.
Electron microscopy. For whole cells, cells were fixed with 6% gluteraldehyde
(Merck, Darmstadt, Germany), washed in phosphate-buffered saline, stained
with uranyl acetate and lead citrate, and examined under a JEOL transmission
electron microscope at 60 kV. For thin-section electron microscopy, cells were
fixed first with 6% gluteraldehyde in 0.125 M phosphate buffer (pH 7.2) for 14 to
16 h and then with 1% osmium tetroxide (Ted Pella, Inc., Tustin, Calif.) in
Kellenberger buffer for 16 to 20 h at room temperature. The fixed cells were
washed for 2 h in 0.5% uranyl acetate in the above buffer, dehydrated with
ascending concentrations of ethanol, and embedded in spur medium (Poly Sci-
ences, Inc., Warrington, Pa.) at 70°C for 48 h as described previously (13).
Sections were cut with a Du Pont diamond knife on an LKB Nova ultramic-
rotome and stained with uranyl acetate and lead citrate. To visualize the pepti-
doglycan, a special staining procedure as described elsewhere (11) was used. The
sections were floated on 1% periodic acid for 15 min, rinsed with distilled water,
and treated with phosphotungstic acid in 10% chromic acid and rinsed for 10 min
in distilled water. These were then examined under a JEOL transmission elec-
tron microscope at 60 kV.
Protein labeling in maxicells. Plasmid-coded proteins were examined using
the maxicell technique (23). Strain CSR603 carrying either pBluescript or
pAMT150 was grown (2 3 108 CFU/ml) in M9 medium containing 1% casamino
acids. The cell pellet was suspended in the dilution buffer and irradiated with UV
light (50 J/m2). The irradiated cells were suspended in fresh medium and incu-
bated at 37°C for 1 h. At the end of this period, 200 mg of D-cycloserine per ml
was added, and the incubation was continued for 16 h at 37°C with constant
shaking at slow speed. The cells were harvested, washed and suspended in fresh
sulfur-depleted medium, and incubated at 37°C for 1 h. The plasmid-coded
proteins were then labeled with [35S]methionine (5 mCi/ml) for 1 h at 37°C. The
cells were harvested and washed with M9 medium, and the cell lysate was
analyzed by sodium dodecyl sulfate (SDS)–15% PAGE followed by fluorography
and autoradiography of the dried gel.
Nucleotide sequence accession numbers. The nucleotide and deduced amino
acid sequences of the V. cholerae murE gene appear in the EMBL, GenBank, and
DDBJ databases under accession no. AF141867. The nucleotide sequences of
RAP products appear under accession nos. AF211980, AF211981, AF211982,
AF211983, and AF217393.
RESULTS
Comparison of swarming ability of in vivo- and in vitro-
grown V. cholerae on motility agar plates. It has recently been
reported that expression of the major virulence factors and
motility are oppositely regulated in V. cholerae (7). Inside the
FIG. 3. Serum assays of behavior of V. cholerae cells grown in vitro (L) and in vivo (R) in 20, 40, 60, and 80% serum (S) or heat inactivated-serum (IS) with an
inoculum of 2 3 109 cells. Samples were taken in duplicate at the start and after 2 h of incubation. Results are shown as percent viability.
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host, the motility of the bacteria is important for their move-
ment from the point of ingestion to a niche in the small intes-
tine, where they colonize. The swarming ability of the in vivo-
grown cells in semisolid motility medium containing 0.3% agar
in LB medium (pH 7.2) was compared with that of V. cholerae
cells in the exponential phase grown under laboratory condi-
tions. Under these conditions, the in vitro-grown 569B cells
displayed little motility in the swarm plates. However, the in
vivo-grown cells were significantly more motile, and a 350%
increase in swarm diameter was observed (Fig. 1). This sug-
gests that regulation of the major virulence factors in vivo and
motility may follow an alternative or slightly modified pathway.
Serum sensitivity of in vivo- and in vitro-grown V. cholerae.
Once inside the host, the bacteria have to evade the host
immune system and then colonize the intestine. It has been
reported that mutations in the toxR and tcp genes rendered V.
cholerae more sensitive to the vibriocidal activity of antibody
and complement (19). It is in this context that the serum
sensitivity of in vivo- and in vitro-grown V. cholerae were com-
pared.
Serum samples collected from five healthy individuals were
pooled to eliminate interindividual variation. Serum assays
were performed with normal human serum and heat-inacti-
vated serum. Two different assays were performed. In one, the
concentration of serum was kept at 35% and 2 3 109 bacterial
cells isolated and diluted from an exponential-phase or over-
night culture or rabbit intestine were added. The reaction
mixture was incubated at 37°C for 3 h. Viable-cell counts were
determined in duplicate at the end of each hour for 3 h.
The results are shown in Fig. 2 as percent viability. As
expected for inactivated serum in all three cultures, bacteria
increased in number by 150 to 200% in the first hour, with
growth reaching a plateau by the third hour of incubation. In
presence of normal serum, the in vivo-grown bacteria showed
80% killing in the first hour, reached a plateau, and actually
had a slight increase in number after the second hour. In
contrast, the laboratory-grown cultures showed more than 90%
killing in the first hour and mostly did not survive till the
second hour of incubation.
In the other assay, 5 3 109 bacterial cells isolated and diluted
from an exponential-phase or overnight culture or rabbit in-
testine were incubated for 2 h at 37°C with both serum and
inactivated serum concentrations of 20, 40, 60, and 80%. Via-
ble-cell counts were determined in duplicate at the end of 2 h.
Figure 3 shows the results as percent viability. It was found that
the in vitro-grown cells did not survive for more than 2 h at
serum concentrations higher than 20%, whereas in vivo-grown
bacteria showed about 25 to 40% survival after 2 h of incuba-
tion.
RAP-PCR fingerprinting of RNA. Bacteria grown under the
appropriate condition were immediately frozen on an ice-salt
mixture to minimize degradation of mRNA, and total RNA
was isolated as described in Materials and Methods. Total
RNA isolated from bacteria grown in the laboratory to the
exponential phase and bacteria from ligated rabbit ileal loops
were subjected to RAP fingerprinting. First-strand cDNA was
synthesized using Moloney murine leukemia virus reverse tran-
scriptase with an arbitrarily selected primer. The arbitrarily
primed first-strand cDNA is heat denatured and subjected to
arbitrarily primed second-strand synthesis using Taq polymer-
ase at low stringency. Products that have the primer sequence
at both ends are then PCR amplified at high stringency with
simultaneous radiolabeling. Products were separated by dena-
turing PAGE and visualized by autoradiography. The resulting
fingerprint patterns were highly reproducible.
Each fingerprint yielded a pattern of 18 or more clearly
visible PCR products (Fig. 4). Pooled RNA samples from at
least four different animals were used for each experiment to
eliminate rabbit-to-rabbit variations. Fingerprints were gener-
ated using eight different primers. For each primer there were
18 or more observable bands in each lane, but only a few
differentially amplified cDNA products were observed. The
RNA was treated with RNase-free DNase prior to fingerprint-
ing. This eliminated the possibility of genomic DNA contam-
ination. Controls without reverse transcriptase were used with
every reaction to rule out possible contamination. Bands spe-
cific to in vivo and in vitro RNA were identified, and differen-
tially amplified RAP products were eluted as described in
Materials and Methods. At least two separate reactions were
performed for each primer for each RNA sample. Only bands
that appeared to be differentially expressed in both the reac-
tions were used for further analysis. These were then cloned
into the SmaI site of the pBluescript vector, and a partial
nucleotide sequence was obtained.
Five differentially expressed transcripts were sequenced, and
the database was searched for homology using the BLASTN
and BLASTX (1) programs (Table 2). None of the transcripts
showed any homology at the nucleotide level except pRAP5. It
is induced in vivo and showed homology to the z62r gene of V.
FIG. 4. RAP-PCR fingerprinting of V. cholerae grown in vivo (R) and in vitro
(L). The arrow shows a differentially expressed band. Lane M, HaeIII-digested
fX174 DNA as markers.
TABLE 2. List of isolated RAP products
Clone Homology Induction
pRAP1 MurE protein of E. coli In vivo
pRAP2 Leucyl-tRNA synthase protein of E. coli In vitro
pRAP3 None found In vivo
pRAP4 50S ribosomal protein of E. coli In vitro
pRAP5 z62r gene of V. cholerae and SucA protein of
E. coli
In vivo
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cholerae in the database. The z62r gene is a hypothetical open
reading frame (ORF) from V. cholerae. At the protein level it
showed homology to the E. coli SucA protein (Fig. 5). Inter-
estingly iviII, an in vivo-induced transcript in V. cholerae re-
ported by Camilli and Mekalanos (3), is also a part of the V.
cholerae sucA gene. SucA is part of a multisubunit enzyme that
catalyzes a step in the tricarboxylic acid cycle in which a-keto-
gluterate is oxidatively decarboxylated to succinyl coenzyme A
and carbon dioxide. pRAP1 induced in vivo was also predicted
to encode a polypeptide that had high similarity to the MurE
protein of E. coli, which catalyzes an intermediate step in the
peptidoglycan biosynthetic pathway (Fig. 5). pRAP2 induced
in vitro was predicted to be part of a gene encoding a polypep-
tide highly homologous to the leucine tRNA synthetase (LeuS)
gene of E. coli (Fig. 5). It catalyzes the binding of L-leucine to
the leucyl-tRNA in the presence of ATP. pRAP4 induced in
vitro was also found to be a part of a gene encoding a polypep-
tide with a very high similarity to the 50S ribosomal protein of
E. coli (Fig. 5). pRAP3 did not show significant homology to
any sequence deposited in the database.
Northern blot analysis. To examine the level of expression
of the differentially expressed transcripts, RNA isolated from
in vivo- and in vitro-grown bacteria was Northern blotted and
probed with the five cDNA fragments isolated by RAP-PCR
(Fig. 6). In some cases RNA dot blots were also used. Specific
signals could be detected in each case. Clones pRAP1, pRAP3,
and pRAP5 showed induction in vivo; pRAP2 and pRAP4
were induced in vitro. The blots were then stripped and re-
probed with a V. cholerae rRNA probe as a control (data not
shown).
Lysis of V. cholerae cells grown in vivo. The structure of the
murein network plays a significant role in determining the
stability of cell surfaces of bacteria. Several studies have indi-
cated the delicate nature of the murein networks of V. cholerae
cells (4, 13, 25). It is a real mystery how these cells survive in
the human intestine. Our finding that a peptidoglycan biosyn-
thetic pathway gene is induced in vivo led us to investigate
whether in vivo-grown cells are equally susceptible to lysis.
Cells isolated from rabbit ileal loops and cells grown in the
laboratory in the stationary or logarithmic phase of growth
were suspended in distilled water, and the extent of lysis was
compared (Fig. 7). For cells in the stationary phase of growth,
the extent of lysis was less than that for cells in the logarithmic
phase of growth. In vivo-grown cells were found to be slightly
less sensitive to lysis upon suspension in distilled water than
those grown in vitro.
Ultrastructure of in vivo-grown cells. The murein network of
a bacterial cell is mainly responsible for its shape and rigidity.
On finding that the murE gene is induced in vivo, we examined
ultrathin sections of V. cholerae cells grown in vivo and in vitro
under the transmission electron microscope. A special perio-
date staining procedure for peptidoglycan was used (11). The
laboratory-grown cells had a barely visible discontinuous mem-
brane structure, whereas in in vivo-grown cells, a typical rigid
railroad pattern was observed (Fig. 8).
The above observations indicated that V. cholerae cells mod-
FIG. 5. Selected results of BLAST search of sequences of the RAP products. E.C., E. coli; 50sRp, 50S ribosomal protein. 1, conserved substitution.
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ulate their peptidoglycan level in vivo, which helps them to
survive in conditions within the host. This is a very new finding,
and to determine if the induced expression of murE is solely
responsible for these phenomena, we decided to clone and
sequence the murE gene of V. cholerae.
murE gene of V. cholerae: cloning, nucleotide sequence, and
protein sequence. The V. cholerae murE gene was cloned by
screening a subgenomic library using the 150-bp cDNA frag-
ment obtained from RAP-PCR fingerprinting as the probe.
The sequence of the 2-kb insert in plasmid pAMT200 con-
tained an ORF of 1,488 nucleotides, which is capable of coding
for a protein of 495 amino acids whose predicted amino acid
sequence is about 56% identical to that of the E. coli MurE
protein. A putative ribosome-binding site (GAGA) was cen-
tered about 10 nucleotides upstream of the translation initia-
tion site. The synthetase activity of the MurE protein requires
ATP hydrolysis, and as previously observed in E. coli (15), a
domain characteristic of ATP-binding proteins was found be-
tween amino acids 121 and 125. Analysis of the sequence
upstream and downstream of murE revealed that the pbpB
gene lies immediately upstream and the murF gene lies imme-
diately downstream. This organization is similar to that in E.
coli. As our aim was to check the effect of expression of murE
in V. cholerae, we amplified a 1,540-bp fragment from the 2-kb
region. This contained the putative ORF for murE and nucle-
otides up to 50 bp upstream of the start codon and thus min-
imized the possibility of the presence of promoter elements
and partial codons of genes downstream of the murE ORF.
The PCR product was ligated into the SmaI site of pBluescript
and designated pAMT150, and the sequence was verified by
cycle sequencing.
The protein(s) encoded by this fragment was examined by
using maxicell analysis (23). Plasmid pAMT150 carrying the
1.5-kb DNA fragment was transformed into E. coli strain
CSR603. Cells of E. coli CSR603 carrying pAMT150 were
irradiated with UV light, labeled with [35S]methionine for 1 h,
and the extract of soluble proteins was assayed by SDS-PAGE
and autoradiography as described in Materials and Methods.
The 1.5-kb DNA fragment was found to encode a protein of 53
kDa (Fig. 9), which is in agreement with the predicted amino
acid sequence of 495 amino acids. Plasmid pAMT150 contain-
ing the murE gene of V. cholerae was transformed into V.
cholerae 569B, and a transformant strain designated 569BME
was obtained. 569BME grew well in the presence of ampicillin
but tended to lose the plasmid in the absence of the antibiotic.
To check if any change in the murein network of this strain has
occurred, the lytic profile of 569BME in distilled water was
FIG. 6. Northern and dot blot analyses of the isolated RAP products pRAP1
(A), pRAP2 (B), pRAP3 (C), pRAP4 (D), and pRAP5 (E). L and R, in vitro and
in vivo RNA, respectively.
FIG. 7. Lytic profile of V. cholerae cells suspended in distilled water. R and N, cells grown in vivo and in vitro, respectively; L and S, logarithmic and stationary phase
of growth, respectively.
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studied as described above. No change in the lytic profile was
observed compared with that of the wild-type 569B.
Ultrathin sections of 569BME were stained and observed
under a transmission electron microscope. Though the cell wall
seemed to be slightly more rigid than that of wild-type 569B,
the difference was not very clear (Fig. 10).
V. cholerae 569B and 569BME cells (about 107 CFU) were
injected separately into ligated rabbit ileal loops, and after 16
to 18 h the animal was sacrificed and the intestinal fluid was
collected. No difference in the amount of fluid accumulated in
loops containing 569B and 569BME was observed. The col-
lected fluid was diluted and plated onto NA and NA-ampicillin
plates. On comparing the counts of 569BME plated onto NA
and NA-ampicillin plates, it was found that 569BME cultured
in rabbit ileal loops lost pAMT150 about four times less often
than when cultured overnight in the laboratory in absence of
antibiotic. This shows that the transformed cells prefer the ileal
loops over laboratory conditions for growth.
DISCUSSION
Our results demonstrate that identification of V. cholerae
genes that are differentially expressed following infection can
be successfully achieved by RAP-PCR fingerprinting. The li-
gated rabbit ileal loop model was chosen because it provides a
close mimicry of the human gut condition. Moreover, it allows
comparison of the pathogenicity of more than one strain in the
same animal. Lastly, compared to mice models, a greater quan-
tity of bacteria could be isolated from each experiment. The
bacteria isolated from the accumulated fluid showed little or
no contamination, proving the hypothesis that once given the
chance to colonize, V. cholerae outgrows all other intestinal
flora.
The swarming ability of the in vivo-grown cells in semisolid
motility medium was measured. In vivo-grown bacteria were
found to have a swarm diameter 350% larger than that of in
vitro-grown bacteria. The swarm plate assay used in this study
represents both motility and chemotaxis; a more detailed study
would involve measuring the speed using state-of-the-art video
microscopy. The in vivo-grown cells were also more resistant to
killing by human serum. This is direct evidence that V. cholerae
cells adapt for survival in the intestinal milieu. It had been
postulated that expression of the major virulence factors and
motility are oppositely regulated in V. cholerae (7). It has also
been reported that mutations in the toxR and tcp genes ren-
FIG. 8. Ultrathin sections of in vivo- and in vitro-grown V. cholerae cells. Magnificaiton for upper panels, 325,000; magnification for lower panels, 380,000.
Arrowheads, outer membrane and peptidogly can layer.
FIG. 9. Maxicell analysis of the proteins encoded by plasmid pAMT150. Two
bands, one for the b-lactamase (b-L) and another corresponding to a 53-kDa
protein, were observed.
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dered V. cholerae more sensitive to the vibriocidal activity of
antibody and complement (19). Therefore, our observation
that an increase in both motility and resistance to serum sen-
sitivity of in vivo-grown bacteria leads us to the hypothesis that
expression of the major virulence genes may follow an alter-
native or a slightly modified pathway in vivo. A more detailed
study involving mutations in candidate genes should be under-
taken to identify the genes responsible for these phenotypes.
A recent paper by Camilli and colleagues (12) provides di-
rect evidence that in the infant mouse model, ToxR-regulated
genes like ctx and tcp are expressed in vivo with a somewhat
different kinetic pattern. We did not get any ToxR- or Tcp-
regulated genes because the technique we used actually am-
plifies and differentiates between mRNA under two or more
different conditions. ToxR- and Tcp-regulated genes have a
considerable level of expression both in vitro and in vivo. We
chose bands that have a considerable and reproducible differ-
ence in expression levels in vivo and in vitro, so this may also
be the reason that we missed the induced expression of these
genes. Also, the results obtained from RAP-PCR analysis are
always limited by the total number of primers or primer com-
binations used.
One of the transcripts found to be induced in vitro was
predicted to encode a polypeptide highly homologous to the
leucine tRNA synthetase (LeuS) gene of E. coli. The LeuS
protein ligates the leucine amino acid to the leucyl-tRNA in
presence of ATP. Thus, by regulation of this enzyme in vitro,
the regulation of synthesis of a wide variety of proteins requir-
ing this particular aminoacyl tRNA can be achieved. The other
in vitro-induced transcript was found to be a part of a gene
encoding a polypeptide with a very high similarity to the 50S
ribosomal protein of E. coli. The 50S ribosomal protein is
required for protein synthesis. In fact, we identified two genes
that are repressed in vivo, and both relate to protein synthesis.
This is not surprising, as in the stressful environment within the
host, very few proteins are allowed to be synthesized at a high
rate. This helps the pathogen make proper use of the limited
resources in vivo and synthesize proteins that are essential for
virulence and survival within the host.
Of the three in vivo-induced cDNA fragments, one corre-
sponded to the already identified iviII gene of V. cholerae.
Interestingly, iviII is actually an in vivo-induced transcript in V.
cholerae, as reported by Camilli and Mekalanos (3). At the
protein level, it showed homology to the E. coli SucA protein.
SucA is part of a multisubunit enzyme that catalyzes a step in
the tricarboxylic acid cycle in which a-ketogluterate is oxida-
tively decarboxylated to succinyl coenzyme A and carbon di-
oxide. The fact that a particular in vivo-induced gene was
identified by two different techniques is an indirect proof of the
reliability and accuracy of both methods. The second in vivo-
induced transcript was predicted to encode a polypeptide that
had high similarity to the MurE protein of E. coli, which cat-
alyzes an intermediate step in the peptidoglycan biosynthetic
pathway. The third cDNA fragment did not show homology to
any sequence in the database.
The fact that murE, a gene involved in the peptidoglycan
biosynthetic pathway, is induced in vivo did not come as a
surprise to us. In fact, several studies have indicated the fragile
nature of the murein networks of V. cholerae cells (4, 13, 25).
In E. coli, the peptidoglycan network is thin but “more than a
monolayer” (10). The peptidoglycan content of V. cholerae
569B is about 0.5% of the cellular dry weight, a percentage
much lower than that in other gram-negative bacteria (13). It
is really intriguing how these cells survive in the human intes-
tine. When the lytic profiles of in vivo- and in vitro-grown cells
suspended in distilled water were compared, the former was
found to be slightly less sensitive to lysis. Ultrathin sections of
both cells observed under the transmission electron micro-
scope revealed that in contrast to the usual wavy discontinuous
membrane structure of the in vitro-grown cells, in vivo-grown
cells had a more rigid, clearly visible double-layered structure.
These experiments were repeated several times, each time with
a different animal, and were reproducible. Moreover, the pe-
riodate method of staining (11) reflects peptidoglycan only.
The increased level of peptidoglycan could be due to differ-
ences in osmolarity, especially since it has been reported ear-
lier that the level of peptidoglycan in V. cholerae grown in 1%
NaCl is higher than when grown without NaCl (13). The
murein network of a cell is responsible for its shape and rigid-
ity, protecting the cell against osmotic shock. This observation
indicates that V. cholerae cells modulate their peptidoglycan
FIG. 10. Ultrathin section of V. cholerae 569BME observed under a transmission electron microscope. Bar, 0.1 mm.
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content in vivo to help them survive in the intestinal environ-
ment.
Using the murE cDNA fragment as probe, the V. cholerae
murE gene was cloned and the cloned gene was confirmed by
comparison of its nucleotide sequence with the database. The
sequence contained an ORF of 1,488 nucleotides with its own
ribosome-binding site. The analysis of sequences upstream and
downstream of the murE gene revealed that the organization
of the locus in V. cholerae is similar to that in E. coli, with the
pbpB gene immediately upstream and the murF gene immedi-
ately downstream of the predicted ORF. Maxicell analysis re-
vealed a 53-kDa protein, in agreement with the predicted
amino acid sequence of 495 amino acids.
The obvious question arose of whether the change in cell
surface characteristics of V. cholerae in vivo is due to the
induction of murE alone or a multigenic process. A plasmid
containing the murE gene of V. cholerae was transformed into
V. cholerae 569B, and transformed strain 569BME containing
the plasmid was obtained. The lytic profile of V. cholerae
569BME suspended in distilled water did not show any signif-
icant difference compared with the wild-type strain. Ultrastruc-
tural analysis revealed a slightly more rigid and continuous
membrane structure than in the wild-type 569B. This indicates
that although a slightly greater rigidity in the cell surface may
have been imparted by expression of the cloned murE gene, to
achieve the major changes in phenotypes observed in in vivo-
grown cells, a multigene process is involved. To find a more
complete answer to the question, the other genes related to the
cell surface and peptidoglycan structure of V. cholerae need to
be identified and analyzed.
Recent reports showed that the intracellular residence of S.
enterica serovar Typhimurium within epithelial cells is accom-
panied by significant changes in the bacterial cell wall (22). It
has also been reported that environmental non-O1 vibrios are
more resistant to various lytic agents than their O1 counter-
parts and also that they possess more peptidoglycan (4). Our
findings suggest that pathogenic strains of V. cholerae may in
fact modulate their peptidoglycan content in response to en-
vironmental stimuli, as within the host. However, not all the
phenotypic differences observed persist after subculture. Using
promoter reporter constructs, the factors that stimulate the
induction of these can be identified, and the data obtained may
lead to the discovery of new therapeutic and prophylactic
agents against this pathogen.
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